2 Traps For Unwary ANDA Filers
Companies looking to file an abbreviated new drug application ("ANDA") in 2014 should be aware of two draft guidances issued by the U.S. Food and Drug Administration this month. The draft...To view the full article, register now.
Already a subscriber? Click here to view full article